Russia’s Non-Small Cell Lung Cancer Drug Market Growing 3% Annually
This article was originally published in PharmAsia News
Executive Summary
Russia’s market for drugs for treating non-small cell lung cancer is expected to grow by 3% a year for the next four years, enough to amount to a $163 million market in 2015.